Seattle Children’s opens first pediatric CAR T-Cell trial targeting CD22 and CD19 proteins
Credit: Seattle Children's Seattle Children's has opened the first chimeric antigen receptor (CAR) T-cell immunotherapy trial in the U.S. for children and young adults with...







